CLS Holdings USA, Inc. (CLSH) Análisis de Acciones
Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Cotizando a $, CLS Holdings USA, Inc. (CLSH) es una empresa del sector Healthcare valorada en 0. Calificado con 43/100 (cauteloso) en potencial de crecimiento, salud financiera e impulso.
Ultimo analisis: 17 mar 2026CLS Holdings USA, Inc. (CLSH) Resumen de Asistencia Médica y Tuberías
CLS Holdings USA, Inc. operates in the cannabis industry, focusing on the extraction and conversion of cannabinoids into various products. The company sells to licensed retailers and distributors under the Oasis Cannabis and City Trees brands, offering concentrates, edibles, and consulting services within the United States.
Tesis de Inversión
CLS Holdings USA, Inc. presents a speculative investment opportunity within the cannabis sector, characterized by its focus on extraction and branded product sales. With a market capitalization of $0.01 billion and a negative P/E ratio of -16.20, the company's financial performance indicates challenges in achieving profitability. A gross margin of 41.4% suggests potential for operational efficiency, but the negative profit margin of -4.6% highlights the need for improved cost management. Growth catalysts include expansion of its product lines and increased market penetration in existing and new geographic areas. However, investors may want to evaluate the risks associated with the OTC market, regulatory uncertainties, and competition within the cannabis industry. The company's beta of 1.18 indicates higher volatility compared to the overall market.
Basado en las finanzas de FMP y el análisis cuantitativo
Puntos clave
- Market capitalization of $0.01 billion reflects the company's small size and potential for growth or volatility.
- Gross margin of 41.4% indicates a reasonable level of efficiency in production and sales.
- Negative P/E ratio of -16.20 suggests the company is currently not profitable.
- Profit margin of -4.6% highlights the need for improved cost management and revenue generation.
- Beta of 1.18 indicates the stock is more volatile than the overall market.
Competidores y Pares
Fortalezas
- Diversified cannabis product offerings.
- Established brands (Oasis Cannabis and City Trees).
- Expertise in cannabinoid extraction and conversion.
- Provision of consulting services.
Debilidades
- Small market capitalization.
- Negative profitability.
- Limited geographic reach.
- Reliance on the regulatory environment in specific states.
Catalizadores
- Upcoming: Potential changes in cannabis regulations at the state or federal level could create new market opportunities.
- Ongoing: Expansion of the company's product lines to include new cannabis-infused products.
- Ongoing: Strategic partnerships with other cannabis companies to expand market reach.
- Ongoing: Increased focus on branding and marketing to drive customer awareness and loyalty.
Riesgos
- Ongoing: Intense competition in the cannabis industry could pressure margins and market share.
- Potential: Fluctuations in cannabis prices could impact revenue and profitability.
- Ongoing: Changing regulatory landscape could create uncertainty and compliance costs.
- Potential: Limited access to capital could hinder growth initiatives.
- Ongoing: Risks associated with operating on the OTC market, including lower liquidity and higher volatility.
Oportunidades de crecimiento
- Expansion of Product Lines: CLS Holdings has the opportunity to expand its product lines to include new cannabis-infused products, catering to evolving consumer preferences. The market for cannabis edibles and concentrates is projected to grow significantly, offering potential for increased revenue. By introducing innovative products and formulations, CLS Holdings can attract new customers and increase its market share. This expansion could involve developing new flavors, dosages, or delivery methods, such as vape pens or topical creams. The timeline for this growth opportunity is immediate, with ongoing product development efforts.
- Geographic Expansion: CLS Holdings can pursue geographic expansion by entering new markets and establishing operations in states with favorable cannabis regulations. The cannabis market is expanding across the United States, with more states legalizing medical and recreational use. By strategically targeting new markets, CLS Holdings can increase its customer base and revenue streams. This expansion could involve establishing new cultivation facilities, processing plants, or retail locations. The timeline for this growth opportunity is medium-term, with potential for expansion over the next 2-3 years.
- Strategic Partnerships: CLS Holdings can form strategic partnerships with other cannabis companies, including cultivators, distributors, and retailers, to expand its reach and market presence. These partnerships can provide access to new markets, technologies, and resources, enabling CLS Holdings to accelerate its growth. For example, CLS Holdings could partner with a large-scale cultivator to secure a reliable supply of cannabis or with a retail chain to distribute its products. The timeline for this growth opportunity is ongoing, with potential for partnerships to be formed at any time.
- Increased Focus on Branding: CLS Holdings can invest in branding and marketing efforts to increase awareness of its Oasis Cannabis and City Trees brands and differentiate its products from competitors. A strong brand can create customer loyalty and increase sales. This could involve developing a consistent brand identity, launching marketing campaigns, and engaging with customers through social media and events. The timeline for this growth opportunity is ongoing, with continuous efforts to build brand awareness and loyalty.
- Development of Proprietary Strains: CLS Holdings can develop proprietary cannabis strains with unique characteristics and effects, creating a competitive advantage in the market. Proprietary strains can command premium prices and attract customers seeking specific experiences. This could involve investing in research and development to breed new strains with desired traits, such as high potency, unique flavors, or specific medical benefits. The timeline for this growth opportunity is long-term, with potential for new strains to be developed over the next 3-5 years.
Oportunidades
- Expansion into new geographic markets.
- Development of new cannabis-infused products.
- Strategic partnerships with other cannabis companies.
- Increased focus on branding and marketing.
Amenazas
- Intense competition in the cannabis industry.
- Changing regulatory landscape.
- Fluctuations in cannabis prices.
- Limited access to capital.
Ventajas competitivas
- Established brands (Oasis Cannabis and City Trees).
- Expertise in cannabinoid extraction and conversion.
- Relationships with licensed retailers and distributors.
- Consulting services provide additional revenue streams and customer relationships.
Acerca de CLSH
CLS Holdings USA, Inc., founded in 2014 and based in Las Vegas, Nevada, operates as a diversified cannabis company specializing in the extraction and conversion of cannabinoids. The company's core business involves extracting cannabinoids from cannabis plants and transforming them into concentrates such as oils, waxes, edibles, and shatters. These products are marketed under the Oasis Cannabis and City Trees brand names. CLS Holdings serves licensed retailers and distributors, offering organic medical cannabis and recreational marijuana cannabis products. In addition to its branded product lines, CLS Holdings provides extraction services for licensed medical cannabis cultivators and sells cannabis strains in vegetative cuttings. The company also offers consulting services to cannabis-related businesses, including growers, dispensaries, and laboratories, as well as toll processing services. CLS Holdings' concentrates are utilized for both pharmaceutical and other purposes, demonstrating the company's diversified approach within the cannabis market.
Qué hacen
- Extracts cannabinoids from cannabis plants.
- Converts cannabinoids into concentrates like oils, waxes, and edibles.
- Sells organic medical cannabis to licensed retailers.
- Sells recreational marijuana cannabis products to licensed distributors and retailers.
- Offers extraction products derived from in-house cannabis production.
- Provides processing and extraction services for licensed medical cannabis cultivators.
- Sells cannabis strains in the form of vegetative cuttings to licensed medical cannabis cultivators.
- Offers consulting services to cannabis-related businesses.
Modelo de Negocio
- Extraction and conversion of cannabinoids into various products.
- Sales of branded cannabis products under Oasis Cannabis and City Trees.
- Provision of extraction and processing services to other cannabis businesses.
- Consulting services for cannabis-related businesses.
Contexto de la Industria
CLS Holdings USA, Inc. operates within the rapidly evolving cannabis industry, which is experiencing significant growth and regulatory changes. The market is characterized by increasing acceptance of cannabis for both medical and recreational use, driving demand for various cannabis products. CLS Holdings competes with other cannabis companies, including ACRDF, ACRHF, BCBCF, CHNC, and FFLWF, focusing on extraction, product development, and distribution. The industry faces regulatory hurdles, varying state laws, and intense competition, requiring companies to adapt and innovate to maintain a competitive edge. Market trends include the increasing popularity of cannabis concentrates and edibles, as well as the expansion of cannabis retail networks.
Clientes Clave
- Licensed cannabis retailers.
- Licensed cannabis distributors.
- Licensed medical cannabis cultivators.
- Cannabis-related businesses (growers, dispensaries, laboratories).
Finanzas
Gráfico e información
Precio de la acción de CLS Holdings USA, Inc. (CLSH): Price data unavailable
Últimas noticias
-
Stocks That Hit 52-Week Lows On Tuesday
· 24 mar 2020
-
Stocks That Hit 52-Week Lows On Thursday
· 27 feb 2020
-
Stocks That Hit 52-Week Lows On Thursday
· 20 feb 2020
-
New 52-Week Lows for Tuesday Morning
· 30 jul 2019
Consenso de analistas
Calificación de Consenso
Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para CLSH.
Objetivos de Precios
Análisis del precio objetivo de Wall Street para CLSH.
MoonshotScore
¿Qué significa esta puntuación?
El MoonshotScore califica el potencial de crecimiento de CLSH en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.
Liderazgo: Andrew J. Glashow
CEO
Andrew J. Glashow serves as the CEO of CLS Holdings USA, Inc., leading the company's strategic direction and operations. His background includes experience in managing teams and driving growth within the cannabis industry. He is responsible for overseeing the company's extraction, production, and sales activities, as well as its consulting services. Glashow's leadership is focused on expanding CLS Holdings' market presence and developing innovative cannabis products. His expertise in the cannabis sector is pivotal to navigating the complex regulatory landscape and capitalizing on growth opportunities.
Historial: Under Andrew J. Glashow's leadership, CLS Holdings has focused on expanding its product lines and increasing its market share in the cannabis industry. He has overseen the development and launch of new cannabis-infused products, as well as the expansion of the company's consulting services. His strategic decisions have aimed at improving operational efficiency and driving revenue growth. However, the company's profitability remains a challenge.
Información del mercado OTC de CLSH
The OTC Other tier represents the lowest tier of the OTC market, encompassing securities that are not eligible for quotation on OTCQX or OTCQB. These securities may include those of companies that are unwilling or unable to meet the financial reporting standards or other requirements for higher tiers. Companies on the OTC Other tier may have limited information available to investors, and trading in these securities can be highly speculative. This tier often includes defunct companies, shell corporations, and companies with questionable business practices.
- Nivel OTC: OTC Other
- Estado de divulgación: Unknown
- Limited information availability due to lower disclosure requirements.
- Higher potential for fraud and manipulation.
- Lower liquidity and wider bid-ask spreads.
- Greater price volatility.
- Increased risk of delisting or company failure.
- Verify the company's financial reporting status and access any available financial statements.
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Review any available news articles or press releases about the company.
- Check for any regulatory filings or legal proceedings involving the company.
- Understand the risks associated with investing in OTC Other stocks.
- Consult with a financial advisor before making any investment decisions.
- The company has been in operation since 2014.
- The company has established brands (Oasis Cannabis and City Trees).
- The company has a team of 80 employees.
- The company provides extraction and consulting services, indicating some level of expertise.
CLSH Preguntas Frecuentes sobre Acciones de Healthcare
¿Cuáles son los factores clave para evaluar CLSH?
CLS Holdings USA, Inc. (CLSH) actualmente tiene una puntuación IA de 43/100, indicando puntuación baja. Fortaleza clave: Diversified cannabis product offerings.. Riesgo principal a monitorear: Ongoing: Intense competition in the cannabis industry could pressure margins and market share.. Esto no es asesoramiento financiero.
¿Qué es el MoonshotScore de CLSH?
CLSH actualmente puntúa 43/100 (Grado D) en el MoonshotScore, lo que sugiere calificación baja. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.
¿Con qué frecuencia se actualizan los datos de CLSH?
Los precios de CLSH se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.
¿Qué dicen los analistas sobre CLSH?
La cobertura de analistas para CLSH incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.
¿Cuáles son los riesgos de invertir en CLSH?
Las categorías de riesgo para CLSH incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Ongoing: Intense competition in the cannabis industry could pressure margins and market share.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.
¿Cuál es la relación P/E de CLSH?
La relación P/E para CLSH compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.
¿Está CLSH sobrevalorada o infravalorada?
Determinar si CLS Holdings USA, Inc. (CLSH) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.
¿Cuál es el rendimiento por dividendo de CLSH?
CLS Holdings USA, Inc. (CLSH) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.
Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.
Recursos Oficiales
Datos proporcionados solo con fines informativos.
- Information is based on available sources and may be subject to change.
- OTC stocks carry higher risks than exchange-listed stocks.
- AI analysis is pending and may provide additional insights.